Literature DB >> 22354371

External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy.

Jay Kumar Chhablani1, Jae Suk Kim, Lingyun Cheng, Igor Kozak, William Freeman.   

Abstract

BACKGROUND: To evaluate the predictors of visual improvement using spectral-domain optical coherence tomography (SD-OCT) in eyes with resistant diabetic macular edema (DME) treated with pars plana vitrectomy.
METHODS: Thirty-four eyes with resistant DME were evaluated in a retrospective manner. Several SD-OCT variables including photoreceptor inner segment/outer segment (IS/OS) junction, external limiting membrane (ELM) integrity, and central macular thickness (CMT) before and after the surgery, were evaluated by two experienced observers, masked to visual acuity. The visual improvement was used as the outcome measure for a stepwise regression, while the OCT factors were used as predictors.
RESULTS: The strongest predictor of vision improvement was pre-operative damage to the ELM (p = 0.0277) compared to IS/OS junction (p = 0.03). Pretreatment central macular thickness was a very weak predictor (p = 0.18) of visual improvement. For each percentage increase of ELM integrity there was a 0.13 letter gain in vision. ELM integrity explained 16% of the visual acuity improvement after treatment, which rose to 21% with the addition of CMT. The addition of IS/OS junction in the model did not add predictive information.
CONCLUSIONS: Evaluation of ELM preoperatively predicts the vision improvement more accurately than the IS/OS junction and CMT in eyes with DME.

Entities:  

Mesh:

Year:  2012        PMID: 22354371     DOI: 10.1007/s00417-012-1968-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema.

Authors:  Anjali S Maheshwary; Stephen F Oster; Ritchie M S Yuson; Lingyun Cheng; Francesca Mojana; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-05-10       Impact factor: 5.258

2.  A controlled study of vitrectomy for diabetic macular edema.

Authors:  Tomohiro Otani; Shoji Kishi
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

3.  Three-dimensional imaging of cystoid macular edema in retinal vein occlusion.

Authors:  Noritatsu Yamaike; Akitaka Tsujikawa; Masafumi Ota; Atsushi Sakamoto; Yuriko Kotera; Mihori Kita; Kazuaki Miyamoto; Nagahisa Yoshimura; Masanori Hangai
Journal:  Ophthalmology       Date:  2007-08-02       Impact factor: 12.079

4.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

5.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.

Authors:  Felice Cardillo Piccolino; Roberta Rigault de la Longrais; Giambattista Ravera; Chiara M Eandi; Luca Ventre; Ali' Abdollahi; Marilisa Manea
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

6.  Optical coherence tomography in unilateral resolved central serous chorioretinopathy.

Authors:  Chiara M Eandi; Juliet E Chung; Felice Cardillo-Piccolino; Richard F Spaide
Journal:  Retina       Date:  2005-06       Impact factor: 4.256

Review 7.  A review of clinical trials of anti-VEGF agents for diabetic retinopathy.

Authors:  Benjamin P Nicholson; Andrew P Schachat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-20       Impact factor: 3.117

8.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

9.  Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair.

Authors:  Lisa S Schocket; Andre J Witkin; James G Fujimoto; Tony H Ko; Joel S Schuman; Adam H Rogers; Caroline Baumal; Elias Reichel; Jay S Duker
Journal:  Ophthalmology       Date:  2006-04       Impact factor: 12.079

10.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12
View more
  31 in total

1.  Macular ischemia and outcome of vitrectomy for diabetic macular edema.

Authors:  Jaeryung Kim; Se Woong Kang; Dong Hoon Shin; Sang Jin Kim; Ga Eun Cho
Journal:  Jpn J Ophthalmol       Date:  2015-08-01       Impact factor: 2.447

2.  Early postoperative changes of the foveal surface in epiretinal membranes: comparison of 23-gauge macular surgery with air vs. balanced salt solution.

Authors:  Martin A Leitritz; Focke Ziemssen; Bogomil Voykov; Spyridon Dimopoulos; Ditta Zobor; Karl U Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-04       Impact factor: 3.117

3.  INTEGRITY OF OUTER RETINAL LAYERS AFTER RESOLUTION OF CENTRAL INVOLVED DIABETIC MACULAR EDEMA.

Authors:  Ilkay Kilic Muftuoglu; Nadia Mendoza; Raouf Gaber; Mostafa Alam; Qisheng You; William R Freeman
Journal:  Retina       Date:  2017-11       Impact factor: 4.256

4.  High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Authors:  Ilkay Kilic Muftuoglu; Frank F Tsai; Raouf Gaber; Mostafa Alam; Amit Meshi; William R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-23       Impact factor: 3.117

5.  Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy.

Authors:  Cyprian Gabriel Ntomoka; Bindu Rajesh; Gachago Muchai Muriithi; Abhilash Goud; Jay Chhablani
Journal:  Eye (Lond)       Date:  2018-02-12       Impact factor: 3.775

6.  One-year outcomes of aflibercept in recurrent or persistent neovascular age-related macular degeneration.

Authors:  Cheryl A Arcinue; Feiyan Ma; Giulio Barteselli; Lucie Sharpsten; Maria Laura Gomez; William R Freeman
Journal:  Am J Ophthalmol       Date:  2014-11-18       Impact factor: 5.258

Review 7.  Treatment of diabetic retinopathy: Recent advances and unresolved challenges.

Authors:  Michael W Stewart
Journal:  World J Diabetes       Date:  2016-08-25

8.  Adaptive optics ophthalmoscopy.

Authors:  Austin Roorda; Jacque L Duncan
Journal:  Annu Rev Vis Sci       Date:  2015-10-14       Impact factor: 6.422

Review 9.  Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema.

Authors:  Shigeo Yoshida; Tomoaki Murakami; Miho Nozaki; Kiyoshi Suzuma; Takayuki Baba; Takao Hirano; Osamu Sawada; Masahiko Sugimoto; Yoshihiro Takamura; Eiko Tsuiki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-30       Impact factor: 3.117

Review 10.  Indicators of Visual Prognosis in Diabetic Macular Oedema.

Authors:  Sagnik Sen; Kim Ramasamy; Sobha Sivaprasad
Journal:  J Pers Med       Date:  2021-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.